NuGen Medical Devices Inc. News Releases

NuGen Announces Filing of Corrective Disclosure Pursuant to OSC Review

Thu, 27 Aug 2026 17:30:00 -0400

Toronto, Ontario--(Newsfile Corp. - August 27, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") announces that further to the review by the Ontario Securities Commission ("OSC") of the Company's continuous disclosure, the Company has made corrective disclosure with respect to the following:the Company has included in its recently filed management information circular dated August 17, 2026 (the "Circular") the executive compensation disclosure for the year ended December...

NuGen Announces Non-Binding LOI to Acquire Sol-Millennium Canada

Thu, 06 Aug 2026 08:07:00 -0400

Toronto, Ontario--(Newsfile Corp. - August 6, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is pleased to announce it has entered a non-binding letter of intent ("LOI") with Sol-Millennium Medical HK Limited ("SolM HK"), the sole shareholder of Sol-Millenium Canada Inc. ("SolM"), dated August 5, 2026 to acquire all of the issued and outstanding common shares of SolM (the "Proposed Transaction"). Each party is currently conducting its respective due diligence and the...

NuGen Adds to Core Patent Portfolio for Future Needle-Free Platforms

Mon, 27 Jul 2026 17:15:00 -0400

Toronto, Ontario--(Newsfile Corp. - July 27, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free drug delivery, today announced the filing of two additional patent applications supporting its current patent portfolio.The new applications focus on high-efficiency spring charging technology and automatic dose-establishment technology. Together with previously announced patent applications relating to the Company's dual-spring injection system, refill...

NuGen Medical Devices Files Patent for Dual Spring Technology Enhancing Needle-Free Injection Performance

Thu, 28 May 2026 13:43:00 -0400

Toronto, Ontario--(Newsfile Corp. - May 28, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle free drug delivery, today announced the filing of a new patent application (Reference No. P105204NL) covering a new fluid injection technology designed to optimize pressure profiles in needle-free drug delivery systems.The new technology enables a controlled, multi-phase injection profile that delivers the high pressure needed for reliable skin penetration,...

NuGen Files Patent for Ready-to-Fill COP/COC Needle-Free Injection Nozzle, Advancing Prefilled Nozzle Technology

Wed, 25 Mar 2026 17:15:00 -0400

Toronto, Ontario--(Newsfile Corp. - March 25, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"), a leader in needle-free drug delivery, today announced the filing of a new patent covering a Ready-to-Fill (RTF) COP/COC injection nozzle designed specifically for pharmaceutical needle-free applications. The nozzle, which is the subject of a newly filed patent application, represents a novel pharmaceutical packaging component that enables needle-free injection using established aseptic...

NuGen Medical Devices Inc. Provides Update on Health Canada License

Thu, 05 Feb 2026 17:15:00 -0500

Toronto, Ontario--(Newsfile Corp. - February 5, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is initiating a temporary halt on its devices in Canada due to the lapse of its license with Health Canada. The Company's Health Canada Licence became expired due to an untimely certificate renewal. This is not a suspension or cancellation related to regulatory compliance or enforcement action. The temporary status does not constitute a product safety risk. However, to...

NuGen Medical Devices Inc. Announces CFO Transition

Fri, 30 Jan 2026 17:15:00 -0500

Toronto, Ontario--(Newsfile Corp. - January 30, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, announces that Veronique Laberge has resigned from her position as Chief Financial Officer and Corporate Secretary. Her resignation is effective January 31, 2026.The Company has appointed Mr. Ajay Mishra as Chief Financial Officer and Corporate Secretary, effective January 31, 2026. Mr. Mishra will assume...

NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

Fri, 16 Jan 2026 17:30:00 -0500

Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is providing a summary of key developments achieved during 2025 across its Research and Development programs, technical capabilities, clinical initiatives, and global commercial activities.2025 Operational HighlightsResearch & DevelopmentDemonstrated feasibility of the Ready-to-Fill Nozzle, (a component used in...

NuGen Medical Devices Announces NHS Drug Tariff Approval for EziAutoJector(R) Product Line in the UK

Fri, 26 Sep 2025 17:30:00 -0400

Toronto, Ontario--(Newsfile Corp. - September 26, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is pleased to announce that its exclusive UK distribution partner, EziAutoJector® Ltd, has received confirmation from the NHS Business Services Authority, on behalf of the Department of Health, that EziAutoJector® products have been approved for inclusion in the NHS Drug Tariff.This milestone provides for...

NuGen Medical Devices Announces New Needle-Free Injection System Featuring Internal Cartridge Technology

Thu, 21 Aug 2025 17:15:00 -0400

Toronto, Ontario--(Newsfile Corp. - August 21, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is pleased to announce research and development of a next-generation needle-free injection system, in drug delivery technology. This innovation, protected under international patent WO2021206553 (granted in the EU and China; pending in Canada and the US), introduces a cartridge-based solution that simplifies drug...